Australia markets closed

MGC Pharmaceuticals Limited (MXC.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0100-0.0010 (-9.09%)
At close: 11:14AM AEDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2022
30/06/2021
30/06/2020
30/06/2019
Total revenue
4,732
4,732
2,963
2,079
656.237
Cost of revenue
2,922
2,922
1,652
1,905
356.642
Gross profit
1,810
1,810
1,310
174.665
299.595
Operating expenses
Research development
1,608
-
-
-
2,866
Selling general and administrative
10,312
10,312
6,313
4,308
3,423
Total operating expenses
16,071
16,071
13,380
11,979
9,339
Operating income or loss
-14,261
-14,261
-12,070
-11,805
-9,039
Interest expense
210.142
210.142
369.135
135.582
8
Total other income/expenses net
-6,297
-6,297
-3,005
-6,842
6,969
Income before tax
-20,768
-20,768
-15,437
-18,770
-1,876
Income tax expense
0
0
-27.278
0
27.315
Income from continuing operations
-20,768
-20,768
-15,409
-18,770
-1,904
Net income
-20,347
-20,347
-15,870
-19,363
-2,309
Net income available to common shareholders
-20,347
-20,347
-15,870
-19,363
-2,309
Basic EPS
-
-
-0.01
-0.01
-0.00
Diluted EPS
-
-
-0.01
-0.01
-0.00
Basic average shares
-
-
1,906,115
1,382,195
1,209,142
Diluted average shares
-
-
1,906,115
1,382,195
1,209,142
EBITDA
-
-20,310
-14,576
-18,153
-1,609